Pemphigus Vulgaris Triggered by Glibenclamide and Cilazapril by Ilan Goldberg et al.
153
Pemphigus Vulgaris Triggered by Glibenclamide and 
Cilazapril
Ilan Goldberg1, Aushrat Sasson1, Andrea Gat2, Avigdor Srebrnik1, Sarah Brenner1 
Departments of 1Dermatology and 2Pathology, Tel Aviv Sourasky Medical Center, 
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Corresponding author:
Professor Sarah Brenner, MD 
Department of Dermatology
Tel Aviv Sourasky Medical Center
6 Weizmann Street
Tel Aviv 64239 
Israel
derma@tasmc.health.gov.il
Received: April 13, 2005.
Accepted: May 5, 2005.
SUMMARY A case of pemphigus triggered by glibenclamide 
and cilazapril is described. The suspicion of drug induction 
was confirmed in a laboratory study in which a pemphigus-
like effect was induced by glibenclamide in cultured human 
skin explants. Withdrawal of the drugs and their replacement 
by hydrochlorothiazide and metformin resulted in subsidence 
of the lesions and no appearance of new lesions. The labora-
tory study carried out to verify the suspicion of drug induced 
pemphigus and to confirm the diagnosis proved useful in the 
differential diagnosis in this case.
KEY WORDS  cilazapril, drug-induced pemphigus, gliben-
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INTRODUCTION
 Pemphigus is an autoimmune disease, the on-
set and progression of which depend on an inter-
action between genetic predisposition and exog-
enous factors such as drugs and diet (1-3). There 
are a number of reports in the literature of pemphi-
gus developing after treatment with glibenclamide 
and cilazapril (4-6). We describe a case of pemphi-
gus vulgaris that appeared to have been induced 
by these two drugs. Evidence was obtained in a 
laboratory study in which a pemphigus-like effect 
was induced by glibenclamide in cultured human 
skin explants.
CASE REPORT
 A 75-year-old Jewish man was admitted to 
the hospital for erosions over the back, right ear, 
chest, scalp and buccal mucosa persisting for 
six weeks. He had a history of diabetes mellitus 
and hypertension, for which he was treated with 
glibenclamide and cilazapril, an angiotensin-con-
verting enzyme (ACE) inhibitor. Histologic and 
immunofluorescence studies on a biopsy speci-
men confirmed the diagnosis of pemphigus vul-
garis. There was no family history of the disease. 
Systemic treatment with prednisone, 100 mg per 
day, resulted in only mild regression of the erup-
tion. Suspecting the eruption was drug-induced, 
we conducted a laboratory investigation in which 
a biopsy specimen from intact skin of the patient 
was cultured with glibenclamide at concentrations 
of 0.25, 1 and 5 mM. Human breast skin from a 
healthy woman undergoing mastopexy was also 
cultured with these same concentrations of gliben-
clamide. As control, we cultured intact skin of the 
patient and a specimen from the healthy woman in 
a drug-free medium.
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 Suprabasal acantholysis was detected in all 
specimens cultured with the drug (Fig. 1), both 
from the pemphigus patient and the control sub-
ject, regardless of concentration. No structural 
changes were detected in the intact skin of the pa-
tient or in the specimen from the healthy woman 
that were cultured in a drug-free medium.
 Based on these results and literature reports 
implicating this drug and cilazapril in pemphigus 
induction (4-6), we changed the patient’s medica-
tions to hydrochlorothiazide and metformin. The 
lesions subsided and no new lesions appeared.
DISCUSSION
 Drugs that induce pemphigus are divided into 
three groups according to their chemical structure: 
1) thiol drugs (containing a sulfhydryl (SH-) group); 
2) phenol drugs; and 3) nonthiol nonphenol drugs. 
Glibenclamide and cilazapril are nonthiol non-
phenol drugs. Paterson et al. (4) report on a case 
of glibenclamide-induced pemphigus, in which 
the lesions subsided after discontinuation of the 
drug. Two cases have been reported with cilaza-
pril (5,6), with subsidence of the lesions following 
withdrawal of the drug. Thiol drugs and phenol 
drugs are able to induce acantholytic changes in 
tissue cultures (7-9). The suggested mechanisms 
for acantholysis related to thiol drugs include (7): 
direct biochemical impairment to cell adhesion by 
thiol-cysteine bonds; inhibition of enzymes that 
aggregate keratinocytes; activation of enzymes 
like proteases and plasminogen activator that 
disaggregate keratinocytes; and an immune reac-
tion consisting of the formation of neoantigen and 
the consequent production of autoantibodies that 
cross-react with the native molecule and provoke 
pemphigus.
 The possible mechanisms for phenol-induced 
pemphigus include the induction of IL-1α and 
TNF-α release by keratinocytes. These cytokines 
have been demonstrated to play a role in the regu-
lation and synthesis of complement and proteases 
like plasminogen activator, which has been impli-
cated in the pathogenesis of acantholysis in pem-
phigus vulgaris (10,11). 
 The literature contains several reports of ACE 
inhibitors associated with pemphigus (12,13). 
Enalapril was found to be a powerful acantholytic 
drug in vitro (14), and glibenclamide was found in 
our study to be an acantholytic drug. More research 
is needed to understand the exact mechanism of 
the acantholysis induced by glibenclamide. It is in-
teresting to note that glibenclamide is not exactly 
a thiol drug but it is one of the sulphonylureas and 
has sulfur (S-) in its molecule (Fig. 2), so the pos-
sible pathogenic mechanism is an inhibitory effect 
on the epidermal enzymes involved in cell-to-cell 
adhesion.
CONCLUSION
 Our case highlights the usefulness of the de-
scribed laboratory investigation in the differential 
diagnosis and confirmation of drug induction of 
pemphigus.
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Figure 2. Chemical structure of glibenclamide.
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healthy woman. The specimen was cultured with 
glibenclamide at a concentration of 0.25 mM
ACTA DERMATOVENEROLOGICA CROATICA 155
4. Paterson AJ, Lamey PJ, Lewis MA, Nolan A, 
Rademaker M. Pemphigus vulgaris precipi-
tated by glibenclamide therapy. J Oral Pathol 
Med 1993;22:92-5.
5. Buzon E, Perez-Bernal AM, de la Pena F, 
Rios JJ, Camacho F. Pemphigus foliaceus as-
sociated with cilazapril. Acta Derm Venereol 
1998;78:227.
6. Orion E, Gazit E, Brenner S. Pemphigus vul-
garis possibly triggered by cilazapril. Acta 
Derm Venereol 2000;80:220.
7. Ruocco V, De Angelis E, Lombardi ML. Drug-
induced pemphigus II. Pathomechanisms and 
experimental investigations. Clin Dermatol 
1993;11:507-13.
8. Brenner S, Ruocco V, Ruocco E, Russo A, Tur 
E, Luongo V, et al. In vitro tannin acantholysis. 
Int J Dermatol 2000;39:738-42.
9. Brenner S, Srebrnik A, Goldberg I. Pemphigus 
can be induced by topical phenol as well as by 
drugs that contain phenols or thiols. J Cosm 
Dermatol 2003;2:161.
10. Newby CS, Barr RM, Greaves MW, Mallet AI. 
Cytokine release and cytotoxicity in human 
keratinocytes and fibroblasts induced by phe-
nols and sodium dodecyl sulfate. J Invest Der-
matol 2000;115:292-8.
11. Feliciani C, Toto P, Amerio P, Pour SM, 
Coscione G, Shivji G, et al. In vitro and in 
vivo expression of IL-1 alpha and TNF-alpha 
mRNA in pemphigus vulgaris: IL-1 alpha and 
TNF-alpha are involved in acantholysis. J In-
vest Dermatol 2000;114:71-7.
12. Kaplan RP, Potter TS, Fox JN. Drug-induced 
pemphigus related to angiotensin-convert-
ing enzyme inhibitors. J Am Acad Dermatol 
1992;26:364-6.
13. Ong CS, Cook N, Lee S. Drug-related pem-
phigus and angiotensin converting enzyme in-
hibitors. Australas J Dermatol 2000;41:242-6.
14. de Angelis E, Lombardi ML, Grassi M, Ruocco 
V. Enalapril: a powerful in vitro non-thiol acan-
tholytic agent. Int J Dermatol 1992;31:722-4.
Goldberg et al.:   Acta Dermatovenerol Croat
Pemphigus due to glibenclamide and cilazapril  2005;13(3):153-155
Protect your skin with Nivea cream! 
From the Nivea collection of Zlatko Puntijar 
Ask for Nivea cream yours barber. 
From the Nivea collection of Zlatko Puntijar 
During travels, at sport and recreation, use Nivea cream and Nivea oil! 
From the Nivea collection of Zlatko Puntijar 
During travels, at sport and recr ation, use Nive  cream and Nivea oil!
From the Nivea collection of Zlatko Puntijar
